Atlas Trials

A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer

Clinical trial NCT05934461 · COMPLETED

Trial details

NCT number
NCT05934461
Sponsor
Laibin People's Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
The Primary Study Metric is Progression-free Survival (PFS)
Start date
2014-12-01
Primary completion
2022-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.